Fundamentals of Nanocarriers and Probiotics in the Treatment of Cervical Cancer

Author(s): Amandeep Singh, Deepa Negi, Simranjeet Kaur, Sankha Bhattachary*, Gurmeet Singh

Journal Name: Current Nanomedicine
Formerly Recent Patents on Nanomedicine

Volume 10 , Issue 4 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Cancer is a pivotal disease, which is a serious concern towards scientific research. In the recent era of scientific discovery and innovation, probiotics have been proposed as a new preventive and therapeutic option in therapy and to control cancer growth. Probiotics may thus offer a new way in research to investigate active compounds in different probiotic strains having anticancer features. Studies in laboratory animals and cell lines with respect to cancer treatments are encouraging. With rare conventional treatments, the need for new alternatives as the transportation of chemotherapeutic agents by nanocarriers using nanotechnology is one such approach. This review considers various drug delivery systems used in the therapy of cervical cancer, such as dendrimers, liposomes and nanoparticles. These drug delivery systems assist in the improvement of pharmacological activity, solubility, bioavailability and, thus, facilitating new innovative therapeutic technologies. This review summarizes the application of nanotechnology and probiotics in the treatment of cervical cancer.

Keywords: Carcinoma, cervical cancer, liposomes, nanocarrier, novel drug delivery system, probiotics.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 10
ISSUE: 4
Year: 2020
Published on: 28 December, 2020
Page: [342 - 357]
Pages: 16
DOI: 10.2174/2468187310999201105143429
Price: $65

Article Metrics

PDF: 4